Summary
- Current Price
- As of today, RIGL price is $25.81, down -2.12% on
- Current Price All-Time High
- RIGL price is currently -97.75% below its historical high of $1,147.50 set on
- Market Cap
- RIGL current market cap is $468M, up +42.58% over the past 365 days
- PE Ratio
- RIGL current PE ratio is 1.36
- Revenue
- RIGL current annual revenue is $294.28M, up +64.15% year-over-year
- Next Earnings
- The next earnings release for RIGL is on
Profile
| Metric | Value |
|---|---|
| Full Name | Rigel Pharmaceuticals, Inc. |
| Ticker | NASDAQ: RIGL |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | rigel.com |
| Employees | 162 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $25.81 | |
| Price, 1D Change | -2.12% | |
| $468M | ||
| - | ||
| 1.36 | ||
| 0.82 | ||
| $294M | ||
| Revenue, 1Y Change | +64.15% | |
| $19.48 | ||
| EPS, 1Y Change | +1,870.57% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $19.48 | ||
| EPS Estimate | N/A | $4.80 |
| EPS Est. Change | N/A | -75.36% |
| $294.28M | ||
| Revenue Estimate | N/A | $284.13M |
| Revenue Est. Change | N/A | -3.45% |
| Current Price | $25.81 | |
| Price Target | - | $50.00 |
| Price Tgt. Change | - | +93.72% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $0.39 | $0.99 | +150.34% | |
| $6.64 | $19.48 | +193.47% | |
| $4.80 | N/A | -75.36% | |
| $4.80 | N/A | -75.38% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $179.29M | $179.28M | -0.01% | |
| $293.19M | $294.28M | +0.37% | |
| $284.13M | N/A | -3.45% | |
| $320.34M | N/A | +8.85% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $25.81 | |
| $32.89 | ||
| SMA 200 vs Price | +27.44% | |
| $32.43 | ||
| SMA 50 vs Price | +25.64% | |
| 0.82 | ||
| $1.36 | ||
| 30.18 | ||
| 32.03% | ||
| 69.46% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $294.28M | ||
| $19.48 | ||
| $274.66M | ||
| 93.33% | ||
| $125.47M | ||
| 42.63% | ||
| $367.02M | ||
| - | ||
| $127.88M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.14 | ||
| 2.42 | ||
| 2.30 | ||
| - | ||
| 7 | ||
| 0.67 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 1.36 | ||
| 1.59 | ||
| 1.20 | ||
| 2.87 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $391.48M | ||
| $154.96M | ||
| $560.62M | ||
| $240.17M | ||
| $169.14M | ||
| $99.24M | ||
| $53.30M | ||
| $30.43M | ||
| $7.19M |
Expenses
| Metric | Date | Value |
|---|---|---|
| -$72.74M | ||
| $149.20M | ||
| $19.62M | ||
| $0.00 | ||
| $2.42M | ||
| $0.00 | ||
| -$245.20M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $75.66M | ||
| -$92.37M | ||
| $601.00K | ||
| $0.00 | ||
| $75.66M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Jefferies | → | |
| Cantor Fitzgerald | → | |
| HC Wainwright & Co. | → | |
| Cantor Fitzgerald | → | |
| Cantor Fitzgerald | → | |
| Citigroup | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RIGL
FAQ
What is the ticker symbol for Rigel Pharmaceuticals, Inc.?
The ticker symbol for Rigel Pharmaceuticals, Inc. is NASDAQ:RIGL
Does Rigel Pharmaceuticals, Inc. pay dividends?
No, Rigel Pharmaceuticals, Inc. does not pay dividends
What sector is Rigel Pharmaceuticals, Inc. in?
Rigel Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Rigel Pharmaceuticals, Inc. in?
Rigel Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Rigel Pharmaceuticals, Inc. based in?
Rigel Pharmaceuticals, Inc. is headquartered in United States
When did Rigel Pharmaceuticals, Inc. go public?
Rigel Pharmaceuticals, Inc. initial public offering (IPO) was on November 29, 2000
Is Rigel Pharmaceuticals, Inc. in the S&P 500?
No, Rigel Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Rigel Pharmaceuticals, Inc. in the NASDAQ 100?
No, Rigel Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Rigel Pharmaceuticals, Inc. in the Dow Jones?
No, Rigel Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Rigel Pharmaceuticals, Inc. last earnings report?
Rigel Pharmaceuticals, Inc.'s most recent earnings report was on March 3, 2026
When does Rigel Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Rigel Pharmaceuticals, Inc. is May 5, 2026
Data Sources & References
- RIGL Official Website www.rigel.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1034842/000103484226000015/0001034842-26-000015-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1034842/000103484226000015/0001034842-26-000015-index.htm
- RIGL Profile on Yahoo Finance finance.yahoo.com/quote/RIGL
- RIGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rigl